Cardiovascular Risk Factors and Target Organ Damage in Adolescents: The SHIP AHOY Study.
Journal
Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
accepted:
01
03
2022
pubmed:
4
5
2022
medline:
3
6
2022
entrez:
3
5
2022
Statut:
ppublish
Résumé
Development of cardiovascular disease in adults has been directly linked to an adverse metabolic phenotype. While there is evidence that development of these risk factors in childhood persists into adulthood and the development of cardiovascular disease, less is known about whether these risk factors are associated with target organ damage during adolescence. We collected data from 379 adolescents (mean age 15.5, 60% male) with blood pressure between the 75th and 95th percentile to determine if there is a metabolic phenotype that predicts cardiovascular changes (left ventricular mass, systolic and diastolic function, pulse wave velocity, and renal function). We determined the number of risk factors for cardiovascular disease (hypertension, dyslipidemia, obesity, and insulin resistance) present in each participant. Generalized linear models were constructed to determine if the number of cardiovascular risk factors (CVRFs) were associated with measures of target organ damage. The number of CVRFs present were associated with statistically significant differences in increased left ventricular mass index, increased pulse wave velocity, decreased peak longitudinal strain, urine albumin to creatine ratio and echocardiographic parameters of diastolic dysfunction. Generalized linear models showed that dyslipidemia and insulin resistance were independently associated with markers of diastolic dysfunction (P ≤ .05) while increased blood pressure was associated with all makers of target organ damage (P ≤ .03). These data suggest the of the number of CVRFs present is independently associated with early changes in markers of target organ damage during adolescence.
Sections du résumé
BACKGROUND
Development of cardiovascular disease in adults has been directly linked to an adverse metabolic phenotype. While there is evidence that development of these risk factors in childhood persists into adulthood and the development of cardiovascular disease, less is known about whether these risk factors are associated with target organ damage during adolescence.
METHODS
We collected data from 379 adolescents (mean age 15.5, 60% male) with blood pressure between the 75th and 95th percentile to determine if there is a metabolic phenotype that predicts cardiovascular changes (left ventricular mass, systolic and diastolic function, pulse wave velocity, and renal function). We determined the number of risk factors for cardiovascular disease (hypertension, dyslipidemia, obesity, and insulin resistance) present in each participant. Generalized linear models were constructed to determine if the number of cardiovascular risk factors (CVRFs) were associated with measures of target organ damage.
RESULTS
The number of CVRFs present were associated with statistically significant differences in increased left ventricular mass index, increased pulse wave velocity, decreased peak longitudinal strain, urine albumin to creatine ratio and echocardiographic parameters of diastolic dysfunction. Generalized linear models showed that dyslipidemia and insulin resistance were independently associated with markers of diastolic dysfunction (P ≤ .05) while increased blood pressure was associated with all makers of target organ damage (P ≤ .03).
CONCLUSIONS
These data suggest the of the number of CVRFs present is independently associated with early changes in markers of target organ damage during adolescence.
Identifiants
pubmed: 35502610
pii: 186966
doi: 10.1542/peds.2021-054201
pmc: PMC9648121
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Informations de copyright
Copyright © 2022 by the American Academy of Pediatrics.
Références
Acta Diabetol. 2016 Apr;53(2):251-60
pubmed: 26070771
JAMA. 2017 Jun 20;317(23):2417-2426
pubmed: 28632874
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
Pediatrics. 2017 Sep;140(3):
pubmed: 28827377
Am J Med. 2006 Oct;119(10):812-9
pubmed: 17000207
N Engl J Med. 1998 Jun 4;338(23):1650-6
pubmed: 9614255
Circ Cardiovasc Imaging. 2009 Sep;2(5):356-64
pubmed: 19808623
Hypertension. 2015 Sep;66(3):698-722
pubmed: 26160955
Hypertension. 2019 Sep;74(3):590-596
pubmed: 31327264
Pediatr Nephrol. 2009 Aug;24(8):1545-51
pubmed: 19444486
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Am J Cardiol. 1986 Feb 15;57(6):450-8
pubmed: 2936235
Pediatrics. 2007 Aug;120(2):340-5
pubmed: 17671060
Metabolism. 2017 Apr;69:87-95
pubmed: 28285655
Pediatrics. 2007 Feb;119(2):237-46
pubmed: 17272612
Diabetes Care. 2013 Dec;36(12):3938-43
pubmed: 24101697
J Pediatr. 2012 Dec;161(6):991-6
pubmed: 22809659
J Clin Endocrinol Metab. 2006 Aug;91(8):2906-12
pubmed: 16735483
Hypertension. 2020 Jun;75(6):1551-1556
pubmed: 32362230
Pediatrics. 2021 Mar;147(3):
pubmed: 33558307
Pediatr Res. 2018 Nov;84(5):625-631
pubmed: 29899387
Ann Pediatr Cardiol. 2018 Jan-Apr;11(1):28-33
pubmed: 29440827
J Am Coll Cardiol. 2007 Jan 30;49(4):403-14
pubmed: 17258085
J Am Coll Cardiol. 1995 Apr;25(5):1056-62
pubmed: 7897116
Hypertension. 2017 Oct;70(4):683-686
pubmed: 28827475
Curr Cardiol Rev. 2009 May;5(2):133-48
pubmed: 20436854
Hypertension. 2018 Sep;72(3):625-631
pubmed: 29987102
Front Endocrinol (Lausanne). 2020 Sep 24;11:574216
pubmed: 33071981
Int J Obes (Lond). 2011 Oct;35(10):1318-24
pubmed: 21772245
JAMA. 2004 Jul 21;292(3):331-7
pubmed: 15265847
J Am Soc Echocardiogr. 2004 Oct;17(10):1086-119
pubmed: 15452478
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
J Clin Res Pediatr Endocrinol. 2011;3(3):132-8
pubmed: 21911326
J Am Heart Assoc. 2019 Jul 2;8(13):e010150
pubmed: 31213111
Prev Chronic Dis. 2011 May;8(3):A64
pubmed: 21477504